Trevi Therapeutics Inc (TRVI)
2.86
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 10:21
Trevi Therapeutics Max Drawdown (5Y): 95.45% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 95.45% |
| September 30, 2024 | 95.45% |
| August 31, 2024 | 95.45% |
| July 31, 2024 | 95.45% |
| June 30, 2024 | 95.45% |
| May 31, 2024 | 95.45% |
| April 30, 2024 | 95.45% |
| March 31, 2024 | 95.45% |
| February 29, 2024 | 95.45% |
| January 31, 2024 | 95.45% |
| December 31, 2023 | 95.45% |
| November 30, 2023 | 95.45% |
| October 31, 2023 | 95.45% |
| September 30, 2023 | 95.45% |
| August 31, 2023 | 95.45% |
| July 31, 2023 | 95.45% |
| June 30, 2023 | 95.45% |
| May 31, 2023 | 95.45% |
| April 30, 2023 | 95.45% |
| March 31, 2023 | 95.45% |
| February 28, 2023 | 95.45% |
| January 31, 2023 | 95.45% |
| December 31, 2022 | 95.45% |
| November 30, 2022 | 95.45% |
| October 31, 2022 | 95.45% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.45% |
| August 31, 2022 | 95.45% |
| July 31, 2022 | 95.45% |
| June 30, 2022 | 95.45% |
| May 31, 2022 | 95.45% |
| April 30, 2022 | 95.45% |
| March 31, 2022 | 95.45% |
| February 28, 2022 | 95.45% |
| January 31, 2022 | 93.83% |
| December 31, 2021 | 93.28% |
| November 30, 2021 | 90.32% |
| October 31, 2021 | 88.93% |
| September 30, 2021 | 87.25% |
| August 31, 2021 | 83.99% |
| July 31, 2021 | 83.10% |
| June 30, 2021 | 83.10% |
| May 31, 2021 | 83.10% |
| April 30, 2021 | 83.10% |
| March 31, 2021 | 83.10% |
| February 28, 2021 | 83.10% |
| January 31, 2021 | 83.10% |
| December 31, 2020 | 83.10% |
| November 30, 2020 | 83.10% |
| October 31, 2020 | 83.10% |
| September 30, 2020 | 83.10% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.53%
Minimum
Nov 2019
95.45%
Maximum
Feb 2022
89.84%
Average
95.45%
Median
Feb 2022
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.42 |
| Beta (5Y) | 1.009 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 147.5% |
| Historical Sharpe Ratio (5Y) | -0.0163 |
| Historical Sortino (5Y) | -0.0568 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.30% |